Ibrunat

Natco Pharma Ltd

Composition for Ibrunat Products

Ibrunat Products are primarily used for

Mantle-cell lymphoma, Blood cancer (Chronic lymphocytic leukemia)

About Ibrunat Products

Uses of Ibrunat Products

Ibrutinib is used in the treatment of mantle-cell lymphoma and blood cancer (chronic lymphocytic leukemia). It is also used in chronic lymphocytic leukaemia who have received at least one prior therapy or with 17p deletion.

Ibrunat Products side effects

Common

Side Effects of Ibrunat are Headache, Fever, Diarrhea, Stomatitis (Inflammation of the mouth), Nausea, Low blood platelets, Decreased white blood cell count (neutrophils), Fatigue, Musculoskeletal (bone, muscle or joint) pain, Rash, Anemia (low number of red blood cells), Bruising, Muscle spasm, Hemorrhage, Pneumonia, Cough, Dry eye, High blood pressure, Weight loss, Urinary tract infection, Peripheral edema, Subdural hematoma, Second primary malignancies.

Severe

Side Effect of Ibrunat is Tumor lysis syndrome.

Products for Ibrunat

Ibrunat Capsule
bottle of 30 capsules
Natco Pharma Ltd
MRP
9500
Not Available

Substitute brands for Ibrunat

Imbruvica
Janssen Pharmaceuticals
2 Products
Nitib
Hetero Healthcare Limited
1 Product
Bdbrut
BDR Pharmaceuticals Internationals Pvt
1 Product
Ibrukem
Alkem Laboratories Ltd
1 Product
IB-Tib
Cadila Pharmaceuticals Ltd
1 Product

INDIA’S LARGEST HEALTHCARE PLATFORM

LegitScript approved

downArrow